PUBLISHER: The Business Research Company | PRODUCT CODE: 1760477
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760477
Automated microbiology involves the use of automated systems and technologies to perform microbiological tasks that were once carried out manually. The primary goal is to enhance efficiency, minimize human error, improve reproducibility, and accelerate diagnostic processes, particularly in clinical microbiology laboratories.
The main products in automated microbiology include instruments, reagents and kits, and software. Instruments refer to the specialized equipment used for conducting automated microbiological tests, analysis, and diagnostics. These are available in both fully automated and semi-automated versions and utilize various diagnostic technologies, such as DNA sequencing, DNA and RNA probe technology, detection techniques, monoclonal antibodies, and immunoassays. The applications of automated microbiology span across biopharmaceutical production, clinical diagnostics, environmental and water testing, food and beverage testing, and more. Key end users include pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, academic and research institutions, among others.
The automated microbiology market research report is one of a series of new reports from The Business Research Company that provides automated microbiology market statistics, including the automated microbiology industry's global market size, regional shares, competitors with an automated microbiology market share, detailed automated microbiology market segments, market trends and opportunities, and any further data you may need to thrive in the automated microbiology industry. This automated microbiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The automated microbiology market size has grown rapidly in recent years. It will grow from $8.32 billion in 2023 to $9.43 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of infectious diseases, an increasing demand for early diagnosis, a growing need for rapid diagnostic testing, the rise in hospital-acquired infections, and government support for microbial surveillance.
The automated microbiology market size is expected to see rapid growth in the next few years. It will grow to $15.38 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth anticipated in the forecast period can be attributed to several factors, including the increasing adoption of automation in clinical diagnostics, the rising geriatric population, a growing demand for point-of-care diagnostics, the expansion of hospital infrastructure, and a heightened need for antimicrobial resistance detection. Key trends during this period include the adoption of lab-on-a-chip technology, a shift toward fully automated laboratory systems, the rising use of cloud-based data analysis, the integration of artificial intelligence (AI) and machine learning (ML) systems, and the development of portable automated analyzers.
The growing demand for rapid and accurate diagnostics is expected to drive the expansion of the automated microbiology market in the future. Rapid and accurate diagnostics refer to medical testing methods that can quickly and precisely identify infections or diseases, enabling timely and effective treatments. This increased demand is driven by the need for quick disease detection to prevent complications and improve patient outcomes, with minimal waiting time for results. Automated microbiology plays a key role in supporting this demand by enabling high-throughput, standardized, and error-free testing, which ensures faster results and improved patient care. For example, in January 2024, a report from the Global Fund, a Switzerland-based organization focused on AIDS, TB, and malaria prevention and care, noted that the percentage of diagnosed tuberculosis cases using WHO-recommended diagnostic tools rose from 38% in 2021 to 47% in 2022. This highlights the growing adoption of automated diagnostics as a transformative advancement. As a result, the rising demand for rapid and accurate diagnostics is fueling growth in the automated microbiology market.
Innovative solutions are driving growth in the automated microbiology market by enhancing diagnostic accuracy. Leading companies in the market are focusing on the development of advanced technologies, such as matrix-assisted laser desorption/ionization (MALDI) biotyper systems, to improve the speed and precision of microbial identification. MALDI is a mass spectrometry-based technique that identifies microorganisms, including bacteria and fungi, by analyzing their unique protein profiles. For example, in April 2024, Bruker Corporation, a U.S.-based manufacturer of scientific instruments, introduced the MBT Pathfinder IVD robot for automated MALDI Biotyper target preparation. This innovation automates the preparation process for MALDI biotyper analysis, enhancing efficiency in clinical workflows. By streamlining sample loading, matrix application, and plate preparation, the system enables faster and more accurate microorganism identification.
In November 2022, IDEXX Laboratories Inc., a U.S.-based provider of diagnostic technologies and services, acquired Tecta-PDS Inc. for an undisclosed amount. This acquisition enables IDEXX to broaden its portfolio of water microbiology testing solutions, enhancing both laboratory-based and in-field testing capabilities. It aligns with IDEXX's mission to safeguard public health by ensuring access to clean and safe water through innovative diagnostic technologies. Tecta-PDS Inc. is a Canada-based company, specializing in providing automated microbiology solutions.
Major players in the automated microbiology market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Charles River Laboratories, PerkinElmer Inc., bioMerieux SA, Sysmex Corporation, BioRad Laboratories, HORIBA Ltd., DiaSorin S.p.A., Neogen Corporation, Orchard Software Corporation, Era Biology Group, Rapid Micro Biosystems Inc., Avails Medical Inc., Hudson Lab Automation, and Shenzhen YHLO Biotech Co. Ltd.
North America was the largest region in the automated microbiology market in 2024. The regions covered in automated microbiology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the automated microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The automated microbiology market includes of revenues earned by entities by providing services such as microbial identification, rapid molecular diagnostics, and others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The automated microbiology market consists of sales of laboratory automation systems, automated microbiology panels, and automated microbial detection systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automated Microbiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on automated microbiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for automated microbiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The automated microbiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.